Acquisition by Perez Robert J of 20000 shares of Larimar Therapeutics subject to Rule 16b-3
| LRMR Stock | USD 4.18 0.17 4.24% |
Slightly above 54% of Larimar Therapeutics' retail investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Larimar Therapeutics suggests that some traders are interested. Larimar Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Larimar Therapeutics. Many technical investors use Larimar Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Larimar |
Filed transaction by Larimar Therapeutics Inc director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Larimar Therapeutics Fundamental Analysis
We analyze Larimar Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Larimar Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Larimar Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Larimar Therapeutics is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Larimar Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Larimar Therapeutics stock to make a market-neutral strategy. Peer analysis of Larimar Therapeutics could also be used in its relative valuation, which is a method of valuing Larimar Therapeutics by comparing valuation metrics with similar companies.
Peers
Larimar Therapeutics Related Equities
| SRZN | Surrozen | 19.44 | ||||
| CHRS | Coherus BioSciences | 18.57 | ||||
| ALEC | Alector | 8.99 | ||||
| IMRX | Immuneering Corp | 5.88 | ||||
| KZR | Kezar Life | 4.41 | ||||
| CELC | Celcuity LLC | 3.73 | ||||
| BOLT | Bolt Biotherapeutics | 3.51 | ||||
| CABA | Cabaletta Bio | 3.00 | ||||
| IKNA | Ikena Oncology | 2.42 | ||||
| SNDX | Syndax Pharmaceuticals | 2.06 | ||||
| MRUS | Merus BV | 2.03 | ||||
| PCVX | Vaxcyte | 1.87 | ||||
| SPRO | Spero Therapeutics | 1.85 | ||||
| KROS | Keros Therapeutics | 1.13 | ||||
| STRO | Sutro Biopharma | 1.04 | ||||
| DAWN | Day One | 0.94 | ||||
| CNTA | Centessa Pharmaceuticals | 2.80 |
Additional Tools for Larimar Stock Analysis
When running Larimar Therapeutics' price analysis, check to measure Larimar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Larimar Therapeutics is operating at the current time. Most of Larimar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Larimar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Larimar Therapeutics' price. Additionally, you may evaluate how the addition of Larimar Therapeutics to your portfolios can decrease your overall portfolio volatility.